Definitive confirmation of SNEC tumor cells presence has been established by immunoreactivity for cytokeratin and neuroendocrine markers such as chromogranin A, synaptophysin, neuron-specific enolase, and CD56 (26). The gene discussed is NCAM1; the disease is neoplasm.